The global blood screening market is projected to grow from USD 3.85 billion in 2025 to USD 10.41 billion by 2034, at a CAGR of 11.71%. Growth is driven by rising disease prevalence, technological advancements, and increased adoption of preventive healthcare. The NAT segment led by technology, while reagents dominated the product category. Asia-Pacific is expected to grow fastest, with North America maintaining the largest market share.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Blood Screening Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Blood Screening Market, by Technology
8.1.1. Nucleic Acid Amplification Test (NAT)
8.1.1.1. Market Revenue and Forecast
8.1.2. ELISA
8.1.2.1. Market Revenue and Forecast
8.1.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
8.1.3.1. Market Revenue and Forecast
8.1.4. Next Generation Sequencing
8.1.4.1. Market Revenue and Forecast
8.1.5. Western Blotting
8.1.5.1. Market Revenue and Forecast
9.1. Blood Screening Market, by Product
9.1.1. Reagent
9.1.1.1. Market Revenue and Forecast
9.1.2. Instrument
9.1.2.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Technology
10.1.2. Market Revenue and Forecast, by Product
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Technology
10.1.3.2. Market Revenue and Forecast, by Product
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Technology
10.1.4.2. Market Revenue and Forecast, by Product
10.2. Europe
10.2.1. Market Revenue and Forecast, by Technology
10.2.2. Market Revenue and Forecast, by Product
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Technology
10.2.3.2. Market Revenue and Forecast, by Product
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Technology
10.2.4.2. Market Revenue and Forecast, by Product
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Technology
10.2.5.2. Market Revenue and Forecast, by Product
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Technology
10.2.6.2. Market Revenue and Forecast, by Product
10.3. APAC
10.3.1. Market Revenue and Forecast, by Technology
10.3.2. Market Revenue and Forecast, by Product
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Technology
10.3.3.2. Market Revenue and Forecast, by Product
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Technology
10.3.4.2. Market Revenue and Forecast, by Product
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Technology
10.3.5.2. Market Revenue and Forecast, by Product
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Technology
10.3.6.2. Market Revenue and Forecast, by Product
10.4. MEA
10.4.1. Market Revenue and Forecast, by Technology
10.4.2. Market Revenue and Forecast, by Product
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Technology
10.4.3.2. Market Revenue and Forecast, by Product
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Technology
10.4.4.2. Market Revenue and Forecast, by Product
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Technology
10.4.5.2. Market Revenue and Forecast, by Product
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Technology
10.4.6.2. Market Revenue and Forecast, by Product
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Technology
10.5.2. Market Revenue and Forecast, by Product
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Technology
10.5.3.2. Market Revenue and Forecast, by Product
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Technology
10.5.4.2. Market Revenue and Forecast, by Product
11.1. Instrument
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Roche Diagnostics
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bio-Rad Laboratories, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Thermo Fisher Scientific Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Ortho Clinical Diagnostics
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Grifols
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. BioMérieux SA
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Siemens Healthineers
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Becton, Dickinson and Company (BD)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Quest Diagnostics
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description